Search Results - Kay-Martin Hanschmann

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Determination of DTaP vaccine potency by multiplex immunogenicity testing using electrochemiluminescence by Bärbel Friedrichs, Simone Rehg, Kay-Martin Hanschmann, Volker Öppling, Isabelle Bekeredjian-Ding

    Published in npj Vaccines (2024-08-01)
    Get full text
    Article


  2. 2

    A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro by Stefan Schülke, Lothar Vogel, Ann-Christine Junker, Kay-Martin Hanschmann, Adam Flaczyk, Stefan Vieths, Stephan Scheurer

    Published in Journal of Immunology Research (2016-01-01)
    Get full text
    Article


  3. 3

    Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations. by Felix Husslik, Kay-Martin Hanschmann, Ariane Krämer, Christian Seutter von Loetzen, Kristian Schweimer, Iris Bellinghausen, Regina Treudler, Jan C Simon, Lothar Vogel, Elke Völker, Stefanie Randow, Andreas Reuter, Paul Rösch, Stefan Vieths, Thomas Holzhauser, Dirk Schiller

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  4. 4

    Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors by Jan RH Hanauer, Lisa Gottschlich, Dennis Riehl, Tillmann Rusch, Vivian Koch, Katrin Friedrich, Stefan Hutzler, Steffen Prüfer, Thorsten Friedel, Kay-Martin Hanschmann, Robert C Münch, Christian Jost, Andreas Plückthun, Klaus Cichutek, Christian J Buchholz, Michael D Mühlebach

    Published in Molecular Therapy: Oncolytics (2016-01-01)
    Get full text
    Article


Search Tools: